Gallobe, Sheryll .

HRN: 11-61-40  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/20/2022
CEFUROXIME 750MG (VIAL)
09/20/2022
09/27/2022
IV
750mg
Q8
Post OP Prophylaxis

 Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: Non-compliant To Guidelines